Understanding liver regeneration to bring new insights to the mechanisms driving cholangiocarcinoma

Abstract Cancer frequently arises in epithelial tissues subjected to repeated cycles of injury and repair. Improving our understanding of tissue regeneration is, therefore, likely to reveal novel processes with inherent potential for aberration that can lead to carcinoma. These highly conserved rege...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: R. V. Guest, L. Boulter, B. J. Dwyer, S. J. Forbes
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Acceso en línea:https://doaj.org/article/da0e81fe28b04af4a753bfc50253db6a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:da0e81fe28b04af4a753bfc50253db6a
record_format dspace
spelling oai:doaj.org-article:da0e81fe28b04af4a753bfc50253db6a2021-12-02T14:22:13ZUnderstanding liver regeneration to bring new insights to the mechanisms driving cholangiocarcinoma10.1038/s41536-017-0018-z2057-3995https://doaj.org/article/da0e81fe28b04af4a753bfc50253db6a2017-05-01T00:00:00Zhttps://doi.org/10.1038/s41536-017-0018-zhttps://doaj.org/toc/2057-3995Abstract Cancer frequently arises in epithelial tissues subjected to repeated cycles of injury and repair. Improving our understanding of tissue regeneration is, therefore, likely to reveal novel processes with inherent potential for aberration that can lead to carcinoma. These highly conserved regenerative mechanisms are increasingly understood and in the liver are associated with special characteristics that underlie the organ’s legendary capacity for restoration of size and function following even severe or chronic injury. The nature of the injury can determine the cellular source of epithelial regeneration and the signalling mechanisms brought to play. These observations are shaping how we understand and experimentally investigate primary liver cancer, in particular cholangiocarcinoma; a highly invasive malignancy of the bile ducts, resistant to chemotherapy and whose pathogenesis has hitherto been poorly understood. Interestingly, signals that drive liver development become activated in the formation of cholangiocarcinoma, such as Notch and Wnt and may be potential future therapeutic targets. In this review, we summarise the work which has led to the current understanding of the cellular source of cholangiocarcinoma, how the tumour recruits, sustains and is educated by its supporting stromal environment, and the tumour-derived signals that drive the progression and invasion of the cancer. With few current treatments of any true efficacy, advances that will improve our understanding of the mechanisms driving this aggressive malignancy are welcome and may help drive therapeutic developments.R. V. GuestL. BoulterB. J. DwyerS. J. ForbesNature PortfolioarticleMedicineRENnpj Regenerative Medicine, Vol 2, Iss 1, Pp 1-8 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
spellingShingle Medicine
R
R. V. Guest
L. Boulter
B. J. Dwyer
S. J. Forbes
Understanding liver regeneration to bring new insights to the mechanisms driving cholangiocarcinoma
description Abstract Cancer frequently arises in epithelial tissues subjected to repeated cycles of injury and repair. Improving our understanding of tissue regeneration is, therefore, likely to reveal novel processes with inherent potential for aberration that can lead to carcinoma. These highly conserved regenerative mechanisms are increasingly understood and in the liver are associated with special characteristics that underlie the organ’s legendary capacity for restoration of size and function following even severe or chronic injury. The nature of the injury can determine the cellular source of epithelial regeneration and the signalling mechanisms brought to play. These observations are shaping how we understand and experimentally investigate primary liver cancer, in particular cholangiocarcinoma; a highly invasive malignancy of the bile ducts, resistant to chemotherapy and whose pathogenesis has hitherto been poorly understood. Interestingly, signals that drive liver development become activated in the formation of cholangiocarcinoma, such as Notch and Wnt and may be potential future therapeutic targets. In this review, we summarise the work which has led to the current understanding of the cellular source of cholangiocarcinoma, how the tumour recruits, sustains and is educated by its supporting stromal environment, and the tumour-derived signals that drive the progression and invasion of the cancer. With few current treatments of any true efficacy, advances that will improve our understanding of the mechanisms driving this aggressive malignancy are welcome and may help drive therapeutic developments.
format article
author R. V. Guest
L. Boulter
B. J. Dwyer
S. J. Forbes
author_facet R. V. Guest
L. Boulter
B. J. Dwyer
S. J. Forbes
author_sort R. V. Guest
title Understanding liver regeneration to bring new insights to the mechanisms driving cholangiocarcinoma
title_short Understanding liver regeneration to bring new insights to the mechanisms driving cholangiocarcinoma
title_full Understanding liver regeneration to bring new insights to the mechanisms driving cholangiocarcinoma
title_fullStr Understanding liver regeneration to bring new insights to the mechanisms driving cholangiocarcinoma
title_full_unstemmed Understanding liver regeneration to bring new insights to the mechanisms driving cholangiocarcinoma
title_sort understanding liver regeneration to bring new insights to the mechanisms driving cholangiocarcinoma
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/da0e81fe28b04af4a753bfc50253db6a
work_keys_str_mv AT rvguest understandingliverregenerationtobringnewinsightstothemechanismsdrivingcholangiocarcinoma
AT lboulter understandingliverregenerationtobringnewinsightstothemechanismsdrivingcholangiocarcinoma
AT bjdwyer understandingliverregenerationtobringnewinsightstothemechanismsdrivingcholangiocarcinoma
AT sjforbes understandingliverregenerationtobringnewinsightstothemechanismsdrivingcholangiocarcinoma
_version_ 1718391520033243136